Omada Health, Inc. reported $310M of revenue over the trailing twelve months, +48% on the year before. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $310M (to Q2 2026). Net income: $4.3M, trailing twelve months to Q2 2026. Free cash flow: $23M, trailing twelve months to Q2 2026. Operating margin: −0.36%, trailing twelve months to Q2 2026.

OMDAOmada Health, Inc.

Healthcare

$21.55-5.2% 1Y

$21.55

$10.9452 weeks$26.78

OMDA as reported

Omada Health, Inc. reported $310M of revenue over the trailing twelve months, +48% on the year before. 9 reported series are charted on this page, each one as filed.

$310M

Revenue, trailing twelve months · to Q2 2026 · +48% against the twelve months before

Net income: $4.3M
Net income · −113% year on year · trailing twelve months to Q2 2026
Free cash flow: $23M
Free cash flow · −216% year on year · trailing twelve months to Q2 2026
Operating margin: −0.36%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for OMDA, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$310M	+48%	Q2 2026
Net income	$4.3M	−113%	Q2 2026
EPS	$0.23	−106%	Q2 2026
Gross margin	68%	n/a	Q2 2026
Operating margin	−0.36%	n/a	Q2 2026
Net margin	1.1%	n/a	Q2 2026
ROE	−4.6%	n/a	Q2 2026
ROA	−3.5%	n/a	Q2 2026
Free cash flow	$23M	−216%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.